Dr. Jordan Strom is Director of the Echocardiography Laboratory and Director of Echocardiographic Research at Beth Israel Deaconess Medical Center, Assistant Professor of Medicine at Harvard Medical School, and Section Head of Cardiovascular Imaging Research at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. He received his B.S. in Biology from Yale University and an M.D. from Harvard Medical School, before subsequently training in Internal Medicine at the Massachusetts General Hospital and in Cardiovascular Medicine at Beth Israel Deaconess Medical Center where he was Chief Fellow for the 2017-2018 year. He received additional post-graduate training in Clinical Epidemiology and Biostatistics at the Harvard T.H. Chan School of Public Health, receiving an M.Sc. in Epidemiology in May 2018. Dr. Strom was the inaugural fellow and is currently a faculty investigator at the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. His research involves evaluation of the relationship of cardiac structure and function to health outcomes, particularly for valvular heart disease. Additionally, his research focuses on the optimal use and timing of cardiac imaging in practice. He specializes in the analysis of large administrative, registry, and clinical trial data, in particular imaging registries. He has received grant funding for this work from the American Heart Association and the National Institutes of Health and he has published more than 90 peer-reviewed publications in journals such as Circulation, European Heart Journal, and the Annals of Internal Medicine. He serves as a guest editor and Editorial Board member for the Journal of the American Society of Echocardiography and is a member of the ACC Imaging Council Leadership committee. Dr. Strom was a member of the inaugural class of the American Society of Echocardiography’s Leadership Academy and was the inaugural member elected to the ASE Board of Directors in this capacity. In addition to his role as Chair of the ImageGuideEcho Registry committee, he is a member of the ASE Leadership Academy Selection Task Force and additionally is the ACC representative to the board of directors of the Joint Review Committee on Education in Diagnostic Medical Sonography (JRC-DMS) which oversees training in diagnostic medical sonography in the US, the ACC Commissioner to Commission on Accreditation of Allied Health Education Programs (CAAHEP), the largest programmatic accreditor of the health sciences professions, accrediting over 2,100 education programs in 32 health sciences occupations, and a member of the board of directors of the International Contrast Ultrasound Society (ICUS).

Frank J. Rybicki received his PhD in Medical Engineering from MIT in 1995. He chairs the Department of Radiology, Banner University Medical Group, and the University of Arizona - Phoenix. Dr. Rybicki founded the RSNA 3D Printing Special Interest Group. He launched and is Editor-in-Chief of 3D Printing in Medicine (3D Print Med), 2022 IF = 3.7. Dr. Rybicki edited the most widely sold book on medical 3D printing. The second edition of this book 3D Printing at Hospitals and Medical Centers: A Practical Guide for Medical Professionals will be released in January 2024.

Before joining The Hospital for Sick Children (SickKids) as the Division Head of Cardiovascular Surgery in 2019, David Barron was the Senior Cardiac Surgeon at Birmingham Children’s Hospital, UK. David had been a consultant (staff) at Birmingham Children’s Hospital since 1999. He graduated from St. Thomas’ Hospital in London, and had his cardiothoracic training at Papworth Hospital, Southampton, the Royal Brompton Hospital and Great Ormond Street. During his residency, he obtained a doctorate (MD) from Imperial College, London in biomechanical cardiac assist. He is dual qualified in both internal medicine and in cardiothoracic surgery. He was the lead for Congenital Cardiac Training in the UK and has been on the Executive of the British and European Cardiothoracic Societies. David was also a consultant at the Queen Elizabeth, University Hospital Birmingham for Adult Congenital Cardiac Surgery and Honorary Professor at the Department of Child Health, University of Birmingham.

Professor Michelle Williams is a Professor of Cardiovascular Imaging at the University of Edinburgh and Honorary Consultant Radiologist at NHS Lothian. She is Associate Director of the British Heart Foundation Data Science Centre and the Imaging theme lead. Her research centers around multi-modality non-invasive imaging of the heart and blood vessels, including using machine learning and other advanced analytic techniques. She is president of the British Society of Cardiovascular Imaging, member of the executive community of the European Society of Cardiovascular Radiology, member of the Board of Directors of the SCCT, and chair of the SCCT education committee.

Prof Nathan Better is a Clinical Cardiologist and Nuclear Medicine Physician at Cabrini and Royal Melbourne Hospitals and is Chief of Cardiology Research and Director of Physician Training at Cabrini Hospital. He is the past Chairman of the International Advisory Panel of the American Society of Nuclear Cardiology, an Expert Lecturer at the IAEA in Vienna and is on the editorial board of the Journal of Nuclear Cardiology. His major interests include diagnosis and prognosis of coronary artery disease, cardiac amyloid and cardiac CT.

Professor Girish Dwivedi, MD, DM, MRCP (UK), PhD (UK), FESC, FASE, FSCCT, FCSANZ, is the inaugural Wesfarmers Chair in Cardiology at the Harry Perkins Institute of Medical Research, University of Western Australia (UWA), and Consultant Cardiologist at Fiona Stanley Hospital, Murdoch, Perth. He leads the "Advanced Clinical and Translational Cardiovascular Imaging" group at the Harry Perkins Institute of Medical Research (University of Western Australia) and also holds the position of Joint Head of the Cardiovascular Disease and Diabetes Program at Perkins, as well as serving as the Director of the Cardiometabolic Clinic at the Centre for Cardiometabolic Health and Research, Fiona Stanley Hospital. He has >250 manuscripts accepted or published. Several of his original research manuscripts have been published in top-tier journals such as Annals of Internal Medicine, JACC, Circulation, JACC-Imaging, and Circulation Heart Failure. He has written chapters in a highly prestigious book in Cardiology (Principles and Practice of Clinical Cardiovascular Genetics published by Oxford University Press). His group has conducted pioneering work examining the association of inflammation and atherosclerosis. He has utilized a trans-disciplinary approach that involves translational medicine and novel cardiovascular imaging methods in assessing subclinical atherosclerosis in distinct inflammatory clinical phenotypes. This body of work has received many grants and generated several publications in high-impact journals such as Annals of Internal Medicine, Chest, Journal of Nuclear Cardiology, and AJP-Heart and Circulatory Physiology. After arriving in Perth, he has collaborated closely with the Computer Science colleagues at UWA. Dr. Dwivedi started working with a MedTech start-up company based in Perth (Artrya Ltd) soon after its inception as the Chief Medical Officer and as Chief Scientific Officer (since 2021). Their joint research program is focused on the development of artificial intelligence algorithms to automate advanced and novel cardiac CT biomarker assessment towards heart disease events. Dr. Dwivedi contributed to the development of the intellectual property, resulting in a TGA approved product.

Abdul Ihdayhid is a Structural Interventional Cardiologist and Cardiac CT Specialist at Fiona Stanley Hospital, as well as the Director of Cardiology Research. Abdul undertook interventional fellowships at Monash Heart, Monash Medical Centre and a post-doctoral fellowship at the St Paul’s Hospital in Canada, in advanced cardiac imaging and structural heart intervention. He completed his PhD in intracoronary physiology and cardiac CT at Monash University.

Professor and Head of Cardiology Teaching and Research at the University of Notre Dame, Fremantle, Australia. Consultant Clinical Cardiologist specializing in Cardiac Imaging and breathlessness assessment. Regular invited speaker to National and International conferences and many highly cited publications, and Convenor of the CSANZ meeting in 2024. Founder, Director and Chief Investigator of National Echo Database Australia (NEDA). Chief Medical Officer of Echo IQ, an ASX listed company focused on automation and risk detection using echocardiographic data (ASX:EIQ).